Abstract
Introduction [excerpt]: Antimicrobial resistance remains one of the most urgent and complex challenges facing global public health in the 21st century. Among antibiotic resistant bacteria, Acinetobacter baumannii is considered a particularly alarming pathogen due to its propensity for drug resistance, making this bacterium a significant threat to patient safety and hospital infection control efforts [1]. Due to its resistance capability, A. baumannii is classified as one the ESKAPE pathogens, a group of six highly drug-resistant bacterial pathogens notorious for their ability to evade the effects of antimicrobial agents as well as the host immune response [2].
